Caso Clínico I: Enfermedad de Pompe
McGovern MM, Avetisyan R, Sanson BJ, Lidove O.
Disease manifestations and burden of illness in patients with acid sphingomyelinase deficiency (ASMD).
Orphanet J Rare Dis. 2017 ;12:41
Wasserstein M, Dionisi-Vici C, Giugliani R, Hwu WL, Lidove O et al.
Recommendations for clinical monitoring of patients with acid sphingomyelinase deficiency (ASMD).
Mol Genet Metab. 2019 ;126:98-105.
Syed YY. Olipudase Alfa in Non-CNS
Manifestations of Acid Sphingomyelinase Deficiency: A Profile of Its Use.
Clin Drug Investig. 2023 ;43:369-377. Erratum in: Clin Drug Investig. 2023 ;43:667